GlassScriptPhysician profile
Anna Zabrecky
NPI 1033112321
$742.97
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $11.63 · 2022: $14.83 · 2023: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.70 | 2019-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $106.11 | 2019-2023 | Slynd |
| Mayne Pharma Commercial LLC | $58.23 | 2023 | |
| Gynesonics, INC. | $56.40 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $49.77 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $43.20 | 2019 | |
| Pfizer INC. | $41.21 | 2019-2023 | |
| Hologic Sales and Service, LLC | $40.43 | 2022-2023 | Acessa Provu System |
| Therapeuticsmd, INC. | $36.03 | 2019 | |
| Amag Pharmaceuticals, INC. | $35.45 | 2019-2020 | |
| Avion Pharmaceuticals | $26.08 | 2019-2023 | Balcoltra |
| Biogen, INC. | $16.31 | 2023 | |
| Minerva Surgical, INC | $13.72 | 2023 | |
| Ferring Pharmaceuticals INC. | $11.18 | 2019 | |
| Allergan, INC. | $11.08 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Zabrecky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.